Evidence map›Paper›PMID 26239049›Full record

ArticleJournal of lipid research2015

An LC-MS/MS method to quantify acylcarnitine species including isomeric and odd-numbered forms in plasma and tissues.

Pieter Giesbertz, Josef Ecker, Alexander Haag, Britta Spanier, Hannelore Daniel

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 111 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Photobiomodulation Strengthens Muscles via Its Dual Functions in Gut Microbiota.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Pieter GiesbertzNutritional Physiology, Technische Universität München, 85350 Freising, Germany; and ZIEL Institute for Food and Health, 85350 Freising, Germany.
Josef EckerNutritional Physiology, Technische Universität München, 85350 Freising, Germany; and ZIEL Institute for Food and Health, 85350 Freising, Germany.
Alexander HaagNutritional Physiology, Technische Universität München, 85350 Freising, Germany; and ZIEL Institute for Food and Health, 85350 Freising, Germany.
Britta SpanierNutritional Physiology, Technische Universität München, 85350 Freising, Germany; and ZIEL Institute for Food and Health, 85350 Freising, Germany.
Hannelore DanielNutritional Physiology, Technische Universität München, 85350 Freising, Germany; and ZIEL Institute for Food and Health, 85350 Freising, Germany.
Leibniz-Institute for Food Systems Biology at the Technical University of Munich · DETechnical University of Munich · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acylcarnitines are intermediates of fatty acid and amino acid oxidation found in tissues and body fluids. They are important diagnostic markers for inherited diseases of peroxisomal and mitochondrial oxidation processes and were recently described as biomarkers of complex diseases like the metabolic syndrome. Quantification of acylcarnitine species can become challenging because various species occur as isomers and/or have very low concentrations. Here we describe a new LC-MS/MS method for quantification of 56 acylcarnitine species with acyl-chain lengths from C2 to C18. Our method includes amino acid-derived positional isomers, like methacrylyl-carnitine (2-M-C3:1-CN) and crotonyl-carnitine (C4:1-CN), and odd-numbered carbon species, like pentadecanoyl-carnitine (C15:0-CN) and heptadecanoyl-carnitine (C17:0-CN), occurring at very low concentrations in plasma and tissues. Method validation in plasma and liver samples showed high sensitivity and excellent accuracy and precision. In an application to samples from streptozotocin-treated diabetic mice, we identified significantly increased concentrations of acylcarnitines derived from branched-chain amino acid degradation and of odd-numbered straight-chain species, recently proposed as potential biomarkers for the metabolic syndrome. In conclusion, the LC-MS/MS method presented here allows robust quantification of isomeric acylcarnitine species and extends the palette of acylcarnitines with diagnostic potential derived from fatty acid and amino acid metabolism.

Indexed as

Amino AcidsAnimalsCarnitineChromatography, LiquidDiabetes Mellitus, ExperimentalFatty AcidsIsomerismLiverMiceMice, Inbred C57BLOxidation-ReductionTandem Mass SpectrometryacylcarnitineAmino AcidsCarnitineFatty Acidsdiabetesdiagnostic toolsfatty acid/oxidationliquid chromatography-tandem mass spectroscopylivermitochondria

Identifiers

PMID26239049
PMCPMC4583086
OpenAlexW2170438585

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.